Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Clove Bud

Also known as: Clove, clove bud, clove essential oil, CEO, Eugenia caryophyllata, Syzygium aromaticum

Overview

Clove buds are the dried flower buds of Syzygium aromaticum, a plant traditionally used as both a spice and a medicinal herb. The primary supplemental form is clove essential oil (CEO), which is rich in eugenol, a potent phenolic compound. Clove is recognized for its significant antimicrobial, antioxidant, analgesic, and anti-inflammatory properties. While research on clove is moderate, with several systematic reviews on essential oil applications, clinical trials, particularly randomized controlled trials (RCTs) on its pain and antimicrobial effects in humans, are still limited. The quality of evidence varies, and while some systematic reviews exist, meta-analyses are often constrained by the heterogeneity in study designs and dosages across different studies. Despite these limitations, in vitro and animal studies consistently highlight its potential in various health applications.

Benefits

Clove essential oil (CEO) demonstrates several evidence-based benefits, primarily supported by in vitro and animal studies. It exhibits significant analgesic effects, with research showing pain reduction in animal models, particularly in formalin-induced pain tests. This suggests potential pain-relieving properties mediated by opioid and cholinergic systems. CEO also possesses strong antimicrobial activity, proving effective against various pathogens such as E. coli, Staphylococcus aureus, Salmonella typhimurium, and Listeria monocytogenes in dose-dependent in vitro and food packaging applications. Furthermore, CEO is a potent antioxidant, capable of reducing oxidative damage by inhibiting free radicals and lipid peroxidation, which has been shown to extend the shelf life and improve the quality of meat products. While these effects are statistically significant in controlled settings, clinical relevance in humans requires further randomized controlled trials. Population-specific benefits are not yet well-defined in human clinical trials, as most data are derived from laboratory or food preservation studies. Antimicrobial effects are observed within hours in food models, and analgesic effects in animal studies occur shortly after administration.

How it works

The primary active compound in clove essential oil, eugenol, is responsible for most of its therapeutic effects. Eugenol modulates pain pathways by interacting with opioid receptors and ATP-sensitive potassium channels. Its antimicrobial action stems from its ability to disrupt microbial cell membranes and inhibit essential enzyme activity within pathogens. Additionally, CEO acts as a potent free radical scavenger, effectively protecting lipids and proteins from oxidative damage. While the exact mechanisms of absorption and bioavailability in humans are not fully elucidated, traditional use involves both topical and oral administration, suggesting various routes of interaction with the body's systems.

Side effects

Clove is generally considered safe when consumed in culinary amounts. However, the use of concentrated clove essential oil (CEO) requires caution due to its potency. Common side effects associated with topical or high-dose use of CEO include possible mucosal irritation or allergic reactions. More rarely, excessive ingestion of eugenol, the primary active compound in clove, has been linked to hepatotoxicity (liver damage). Clove also has potential drug interactions, particularly with anticoagulants, due to eugenol's blood-thinning properties, which could increase the risk of bleeding. Contraindications include individuals with a known allergy to clove or eugenol. Caution is also advised during pregnancy and breastfeeding due to a lack of sufficient safety data in these populations. It is crucial to use CEO in diluted forms and under professional guidance, especially for internal use, to mitigate potential adverse effects.

Dosage

There is no standardized dosing established for clove as a supplement, and dosages used in research studies vary widely depending on the application and form. In food preservation, clove essential oil (CEO) concentrations typically range from 0.1% to 5%. For potential analgesic or antimicrobial effects, specific clinical doses for human use are not well defined. Traditional topical use often involves diluted essential oil, rather than concentrated forms. Absorption of active compounds from clove may be enhanced when formulated with lipids. Additionally, co-administration with other antioxidants might synergize its effects. Due to the potency of CEO, especially its eugenol content, it is crucial to exercise caution and avoid excessive intake, as high doses have been associated with adverse effects. Users should consult with a healthcare professional before using clove essential oil as a supplement to determine appropriate and safe dosages.

FAQs

Is clove oil safe for oral consumption?

Culinary use of clove is safe. However, concentrated clove essential oil should be used with extreme caution and always diluted, as high doses can be harmful.

How quickly does clove oil work for pain?

Animal studies suggest rapid analgesic effects, but human data are limited. The onset of pain relief in humans is not well established and may vary.

Can clove oil replace antibiotics?

While clove oil possesses antimicrobial properties, it should not be used as a substitute for prescribed antibiotics for treating bacterial infections.

Does clove oil help with blood sugar?

Some traditional claims exist regarding clove oil's effect on blood sugar, but there is currently insufficient robust clinical evidence to support these claims.

Research Sources

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.640128/pdf – This systematic review examined the analgesic properties of essential oils, including clove oil. It found that clove oil significantly reduced formalin-induced pain in animal models, suggesting its pain-relieving effects are mediated by opioid and cholinergic pathways. The study highlighted the need for more human randomized controlled trials due to the limitations of animal studies and small sample sizes.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11047511/ – This in vitro study investigated the antimicrobial effects of clove essential oil (CEO) in food packaging films. It demonstrated dose-dependent antibacterial activity of CEO against common foodborne pathogens like E. coli and S. aureus, with higher concentrations effectively inhibiting bacterial growth. The research supports CEO's potential in food preservation but notes the absence of human clinical data.
https://pubmed.ncbi.nlm.nih.gov/40647967/ – This systematic review, covering studies from 1999 to 2024, evaluated the antioxidant application of CEO in meat products. It concluded that CEO effectively reduces lipid peroxidation and oxidative damage, thereby extending the shelf life of meat. Despite variability in methods and doses across the 43 included studies, the review consistently supports CEO's significant antioxidant potential.
https://www.mdpi.com/2223-7747/14/13/1958 – This source contributes to the understanding of clove's antioxidant properties, reinforcing the findings that clove essential oil can effectively combat oxidative stress. It supports the notion that CEO's ability to scavenge free radicals and inhibit lipid peroxidation makes it a valuable natural antioxidant, particularly in food preservation contexts.